Other than recurrent TP53 and RB1 mutations in small cell neuroendocrine carcinomas of the GI tract and pancreas [62, 63], little is known about the genetic commonalities or differences in these tumors originating outside of the lung. This evidence concerns the gene TP53 and small cell carcinoma.